Changyi Chen1, Hong Chai, Xinwen Wang, Peter H Lin, Qizhi Yao. 1. Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Molecular Surgeon Research Center, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. jchen@bcm.tmc.edu
Abstract
AIMS: Clinically, Chlamydia pneumoniae infection and its heat shock protein 60 (cHSP60) may contribute to atherogenesis; however, its underlying mechanisms are largely unknown. The objective of this study was to determine whether cHSP60 could cause endothelial dysfunction in human coronary artery endothelial cells (HCAECs) and porcine coronary arteries. METHODS AND RESULTS: When HCAECs were treated with recombinant cHSP60, endothelial nitric oxide synthase (eNOS) mRNA and protein levels, enzyme activities, cellular NO levels, mRNA stability, and promoter activities were significantly decreased. Superoxide anion production was significantly increased due to the inhibition of mitochondrial membrane potential and catalase and superoxide dismutase (SOD) activities as well as activation of NADPH oxidase. Antioxidant seleno-l-methionine (SeMet) or SOD mimetic MnTBAP effectively blocked cHSP60-induced eNOS downregulation. In addition, cHSP60 activated mitogen-activated protein kinases (MAPKs) including p38, c-Jun-N-terminal kinase/stress-activated protein kinase, and extracellular signal-regulated kinases. Specific chemical inhibitors or their dominant-negative mutant forms of these MAPKs effectively blocked cHSP60-induced eNOS downregulation. cHSP60-induced eNOS downregulation and oxidative stress were also demonstrated in porcine coronary artery rings in vitro. Functionally, endothelium-dependent vasorelaxation was significantly reduced in cHSP60-treated vessels. CONCLUSION: cHSP60 directly induces eNOS downregulation through oxidative stress and MAPK activation in both HCAECs and porcine coronary arteries, thereby causing endothelial dysfunction.
AIMS: Clinically, Chlamydia pneumoniae infection and its heat shock protein 60 (cHSP60) may contribute to atherogenesis; however, its underlying mechanisms are largely unknown. The objective of this study was to determine whether cHSP60 could cause endothelial dysfunction in human coronary artery endothelial cells (HCAECs) and porcine coronary arteries. METHODS AND RESULTS: When HCAECs were treated with recombinant cHSP60, endothelial nitric oxide synthase (eNOS) mRNA and protein levels, enzyme activities, cellular NO levels, mRNA stability, and promoter activities were significantly decreased. Superoxide anion production was significantly increased due to the inhibition of mitochondrial membrane potential and catalase and superoxide dismutase (SOD) activities as well as activation of NADPH oxidase. Antioxidant seleno-l-methionine (SeMet) or SOD mimetic MnTBAP effectively blocked cHSP60-induced eNOS downregulation. In addition, cHSP60 activated mitogen-activated protein kinases (MAPKs) including p38, c-Jun-N-terminal kinase/stress-activated protein kinase, and extracellular signal-regulated kinases. Specific chemical inhibitors or their dominant-negative mutant forms of these MAPKs effectively blocked cHSP60-induced eNOS downregulation. cHSP60-induced eNOS downregulation and oxidative stress were also demonstrated in porcine coronary artery rings in vitro. Functionally, endothelium-dependent vasorelaxation was significantly reduced in cHSP60-treated vessels. CONCLUSION: cHSP60 directly induces eNOS downregulation through oxidative stress and MAPK activation in both HCAECs and porcine coronary arteries, thereby causing endothelial dysfunction.
Authors: A D Hauer; P de Vos; N Peterse; H ten Cate; Th J C van Berkel; F R M Stassen; J Kuiper Journal: Cardiovasc Res Date: 2005-08-19 Impact factor: 10.787
Authors: Hong Chai; Hui Yang; Shaoyu Yan; Min Li; Peter H Lin; Alan B Lumsden; Qizhi Yao; Changyi Chen Journal: J Acquir Immune Defic Syndr Date: 2005-09-01 Impact factor: 3.731
Authors: Maria Luisa Genova; Milena Merlo Pich; Andrea Bernacchia; Cristina Bianchi; Annalisa Biondi; Carla Bovina; Anna Ida Falasca; Gabriella Formiggini; Giovanna Parenti Castelli; Giorgio Lenaz Journal: Ann N Y Acad Sci Date: 2004-04 Impact factor: 5.691
Authors: Annette R Rodriguez; Germán Plascencia-Villa; Colleen M Witt; Jieh-Juen Yu; Miguel José-Yacamán; James P Chambers; George Perry; M Neal Guentzel; Bernard P Arulanandam Journal: Cell Immunol Date: 2015-04-01 Impact factor: 4.868
Authors: Simone Kreutmayer; Adam Csordas; Jan Kern; Viola Maass; Giovanni Almanzar; Martin Offterdinger; Robert Öllinger; Matthias Maass; Georg Wick Journal: Cell Stress Chaperones Date: 2012-11-29 Impact factor: 3.667